4.6 (191) · $ 15.00 · In stock
SARS-CoV-2 Spike Protein Targeted for Vaccine
How Furin and ACE2 Interact with the Spike on SARS-CoV-2 - Assay Genie
Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies
News & Comment Cellular & Molecular Immunology
Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein - ScienceDirect
Vaccines ++ – COVID Reference
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics, Virology Journal
Vaccines ++ – COVID Reference
Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach - AJMB: Volume 14, Issue 1, Year 2022 - AJMB